Histogram
Visit (Number) vs ESS Total Score
| N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
|---|---|---|---|---|---|---|---|---|
| Baseline (BL) | 1,507 | 10.5 | ± 4.5 | 10.0 | 0.0 | 24.0 | 9 | 1,516 |
| Clinical Evaluation (CE) | 1,506 | 10.5 | ± 4.5 | 10.5 | 0.0 | 24.0 | 10 | 1,516 |
| Diagnostic Visit (DX) | 1,234 | 10.2 | ± 4.4 | 10.0 | 0.0 | 22.0 | 282 | 1,516 |
| CPAP Titration Visit (CPAP) | 1,058 | 9.8 | ± 4.5 | 10.0 | 0.0 | 23.0 | 458 | 1,516 |
| Two Month Post-CPAP Neurocognitive Visit (2M) | 1,516 | 2.8 | ± 7.3 | 4.0 | -7.0 | 22.0 | - | 1,516 |
| Four Month Post-CPAP Neurocognitive Visit (4M) | 830 | 7.6 | ± 4.3 | 7.0 | -1.0 | 23.0 | 686 | 1,516 |
| Six Month Post-CPAP Neurocognitive Visit (6M) | 1,516 | 2.2 | ± 7.2 | 3.0 | -7.0 | 22.0 | - | 1,516 |
Gender vs ESS Total Score
Baseline (BL)
| N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
|---|---|---|---|---|---|---|---|---|
| Total | 1,507 | 10.5 | ± 4.5 | 10.0 | 0.0 | 24.0 | 9 | 1,516 |
| Male | 953 | 10.3 | ± 4.4 | 10.0 | 0.0 | 22.0 | 5 | 958 |
| Female | 554 | 11.0 | ± 4.7 | 11.0 | 0.0 | 24.0 | 4 | 558 |
Gender vs ESS Total Score
Clinical Evaluation (CE)
| N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
|---|---|---|---|---|---|---|---|---|
| Total | 1,506 | 10.5 | ± 4.5 | 10.5 | 0.0 | 24.0 | 10 | 1,516 |
| Male | 952 | 10.3 | ± 4.4 | 10.0 | 0.0 | 22.0 | 6 | 958 |
| Female | 554 | 11.0 | ± 4.7 | 11.0 | 0.0 | 24.0 | 4 | 558 |
Gender vs ESS Total Score
Diagnostic Visit (DX)
| N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
|---|---|---|---|---|---|---|---|---|
| Total | 1,234 | 10.2 | ± 4.4 | 10.0 | 0.0 | 22.0 | 282 | 1,516 |
| Male | 788 | 10.0 | ± 4.2 | 10.0 | 0.0 | 22.0 | 170 | 958 |
| Female | 446 | 10.5 | ± 4.5 | 10.0 | 0.0 | 22.0 | 112 | 558 |
Gender vs ESS Total Score
CPAP Titration Visit (CPAP)
| N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
|---|---|---|---|---|---|---|---|---|
| Total | 1,058 | 9.8 | ± 4.5 | 10.0 | 0.0 | 23.0 | 458 | 1,516 |
| Male | 698 | 9.4 | ± 4.4 | 9.0 | 0.0 | 23.0 | 260 | 958 |
| Female | 360 | 10.4 | ± 4.6 | 10.0 | 0.0 | 22.0 | 198 | 558 |
Gender vs ESS Total Score
Two Month Post-CPAP Neurocognitive Visit (2M)
| N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
|---|---|---|---|---|---|---|---|---|
| Total | 1,516 | 2.8 | ± 7.3 | 4.0 | -7.0 | 22.0 | - | 1,516 |
| Male | 958 | 2.9 | ± 7.2 | 4.0 | -7.0 | 21.0 | - | 958 |
| Female | 558 | 2.6 | ± 7.5 | 3.0 | -7.0 | 22.0 | - | 558 |
Gender vs ESS Total Score
Four Month Post-CPAP Neurocognitive Visit (4M)
| N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
|---|---|---|---|---|---|---|---|---|
| Total | 830 | 7.6 | ± 4.3 | 7.0 | -1.0 | 23.0 | 686 | 1,516 |
| Male | 539 | 7.3 | ± 4.1 | 7.0 | 0.0 | 20.0 | 419 | 958 |
| Female | 291 | 8.1 | ± 4.5 | 8.0 | -1.0 | 23.0 | 267 | 558 |
Gender vs ESS Total Score
Six Month Post-CPAP Neurocognitive Visit (6M)
| N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
|---|---|---|---|---|---|---|---|---|
| Total | 1,516 | 2.2 | ± 7.2 | 3.0 | -7.0 | 22.0 | - | 1,516 |
| Male | 958 | 2.4 | ± 7.1 | 3.0 | -7.0 | 22.0 | - | 958 |
| Female | 558 | 2.0 | ± 7.2 | 2.0 | -7.0 | 19.0 | - | 558 |
Race/Ethnicity vs ESS Total Score
Baseline (BL)
| N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
|---|---|---|---|---|---|---|---|---|
| Total | 1,507 | 10.5 | ± 4.5 | 10.0 | 0.0 | 24.0 | 9 | 1,516 |
| Native American | 28 | 11.5 | ± 4.4 | 11.5 | 3.0 | 20.0 | - | 28 |
| Asian | 89 | 10.6 | ± 4.5 | 11.0 | 1.0 | 20.0 | - | 89 |
| Black | 172 | 11.8 | ± 5.3 | 12.0 | 0.0 | 22.0 | - | 172 |
| Hispanic | 115 | 10.5 | ± 4.9 | 11.0 | 1.0 | 24.0 | 1 | 116 |
| White | 1,094 | 10.3 | ± 4.3 | 10.0 | 0.0 | 22.0 | 8 | 1,102 |
| Other | 9 | 8.9 | ± 5.1 | 9.0 | 1.0 | 16.0 | - | 9 |
Race/Ethnicity vs ESS Total Score
Clinical Evaluation (CE)
| N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
|---|---|---|---|---|---|---|---|---|
| Total | 1,506 | 10.5 | ± 4.5 | 10.5 | 0.0 | 24.0 | 10 | 1,516 |
| Native American | 28 | 11.5 | ± 4.4 | 11.5 | 2.0 | 20.0 | - | 28 |
| Asian | 89 | 10.6 | ± 4.5 | 11.0 | 1.0 | 20.0 | - | 89 |
| Black | 171 | 11.9 | ± 5.3 | 12.0 | 0.0 | 22.0 | 1 | 172 |
| Hispanic | 115 | 10.4 | ± 4.9 | 11.0 | 1.0 | 24.0 | 1 | 116 |
| White | 1,094 | 10.3 | ± 4.3 | 10.0 | 0.0 | 22.0 | 8 | 1,102 |
| Other | 9 | 8.9 | ± 5.1 | 9.0 | 1.0 | 16.0 | - | 9 |
Race/Ethnicity vs ESS Total Score
Diagnostic Visit (DX)
| N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
|---|---|---|---|---|---|---|---|---|
| Total | 1,234 | 10.2 | ± 4.4 | 10.0 | 0.0 | 22.0 | 282 | 1,516 |
| Native American | 19 | 11.2 | ± 4.0 | 12.0 | 3.0 | 18.0 | 9 | 28 |
| Asian | 74 | 10.7 | ± 4.2 | 10.0 | 3.0 | 18.0 | 15 | 89 |
| Black | 122 | 10.7 | ± 4.9 | 10.5 | 1.0 | 22.0 | 50 | 172 |
| Hispanic | 84 | 9.9 | ± 4.4 | 10.0 | 0.0 | 19.0 | 32 | 116 |
| White | 927 | 10.1 | ± 4.3 | 10.0 | 0.0 | 22.0 | 175 | 1,102 |
| Other | 8 | 9.0 | ± 4.7 | 8.5 | 3.0 | 17.0 | 1 | 9 |
Race/Ethnicity vs ESS Total Score
CPAP Titration Visit (CPAP)
| N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
|---|---|---|---|---|---|---|---|---|
| Total | 1,058 | 9.8 | ± 4.5 | 10.0 | 0.0 | 23.0 | 458 | 1,516 |
| Native American | 16 | 11.6 | ± 5.1 | 12.5 | 2.0 | 21.0 | 12 | 28 |
| Asian | 59 | 9.7 | ± 5.0 | 10.0 | 1.0 | 20.0 | 30 | 89 |
| Black | 96 | 10.2 | ± 4.8 | 10.0 | 0.0 | 20.0 | 76 | 172 |
| Hispanic | 72 | 9.8 | ± 4.6 | 10.0 | 0.0 | 22.0 | 44 | 116 |
| White | 810 | 9.7 | ± 4.4 | 10.0 | 0.0 | 23.0 | 292 | 1,102 |
| Other | 5 | 6.0 | ± 4.2 | 7.0 | 0.0 | 11.0 | 4 | 9 |
Race/Ethnicity vs ESS Total Score
Two Month Post-CPAP Neurocognitive Visit (2M)
| N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
|---|---|---|---|---|---|---|---|---|
| Total | 1,516 | 2.8 | ± 7.3 | 4.0 | -7.0 | 22.0 | - | 1,516 |
| Native American | 28 | 1.7 | ± 7.5 | -3.0 | -6.0 | 16.0 | - | 28 |
| Asian | 89 | 2.2 | ± 7.1 | 2.0 | -7.0 | 17.0 | - | 89 |
| Black | 172 | 1.4 | ± 7.6 | -4.0 | -7.0 | 22.0 | - | 172 |
| Hispanic | 116 | 2.6 | ± 7.2 | 3.0 | -7.0 | 17.0 | - | 116 |
| White | 1,102 | 3.2 | ± 7.3 | 4.0 | -7.0 | 19.0 | - | 1,102 |
| Other | 9 | -0.3 | ± 6.6 | -4.0 | -6.0 | 10.0 | - | 9 |
Race/Ethnicity vs ESS Total Score
Four Month Post-CPAP Neurocognitive Visit (4M)
| N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
|---|---|---|---|---|---|---|---|---|
| Total | 830 | 7.6 | ± 4.3 | 7.0 | -1.0 | 23.0 | 686 | 1,516 |
| Native American | 10 | 7.4 | ± 6.0 | 8.0 | 0.0 | 17.0 | 18 | 28 |
| Asian | 48 | 7.8 | ± 4.4 | 8.0 | 0.0 | 17.0 | 41 | 89 |
| Black | 72 | 8.0 | ± 4.6 | 8.0 | 0.0 | 20.0 | 100 | 172 |
| Hispanic | 57 | 7.8 | ± 4.2 | 7.0 | 0.0 | 17.0 | 59 | 116 |
| White | 640 | 7.5 | ± 4.2 | 7.0 | -1.0 | 23.0 | 462 | 1,102 |
| Other | 3 | 10.7 | ± 3.2 | 12.0 | 7.0 | 13.0 | 6 | 9 |
Race/Ethnicity vs ESS Total Score
Six Month Post-CPAP Neurocognitive Visit (6M)
| N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
|---|---|---|---|---|---|---|---|---|
| Total | 1,516 | 2.2 | ± 7.2 | 3.0 | -7.0 | 22.0 | - | 1,516 |
| Native American | 28 | 1.3 | ± 7.6 | -4.0 | -6.0 | 16.0 | - | 28 |
| Asian | 89 | 2.3 | ± 7.3 | 2.0 | -7.0 | 19.0 | - | 89 |
| Black | 172 | 0.7 | ± 7.0 | -4.0 | -7.0 | 19.0 | - | 172 |
| Hispanic | 116 | 2.2 | ± 7.6 | 1.0 | -7.0 | 22.0 | - | 116 |
| White | 1,102 | 2.5 | ± 7.1 | 3.0 | -7.0 | 19.0 | - | 1,102 |
| Other | 9 | 0.1 | ± 7.4 | -4.0 | -6.0 | 13.0 | - | 9 |